Investigators examined the association between opioid dosages and noncancer pain predictions for course management.

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...

Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new study suggests that the medication’s potential risks outweigh its “limited” benefits for chronic ...

Little is known about opioid prescribing patterns in patients with chronic overlapping pain conditions. This study suggests target populations for interventions to manage chronic pain. Objectives: One ...

Adults with chronic pain who participated in New York State's (NYS) Medical Cannabis Program were significantly less likely ...

Once the preliminary work is done, patients can be started (or continued) on opioid therapy. The starting dose and schedule is based on the drug’s pharmacology; the person’s previous opioid exposure ...

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on ...

New research shows adults who use medical marijuana for chronic pain are less likely to require prescription opioids.

Unfortunately, nonopioid analgesics are often disappointingly ineffective against neuropathic pain. Topically applied medications (e.g., capsaicin, lidocaine) may be useful in some cases, especially ...